Annual Working Capital
$10.60 B
+$104.10 M+0.99%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual working capital is currently $10.60 billion, with the most recent change of +$104.10 million (+0.99%) on 31 December 2023. During the last 3 years, it has risen by +$4.34 billion (+69.39%). VRTX annual working capital is now at all-time high.VRTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$5.83 B
+$436.60 M+8.09%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly working capital is currently $5.83 billion, with the most recent change of +$436.60 million (+8.09%) on 30 September 2024. Over the past year, it has dropped by -$5.27 billion (-47.45%). VRTX quarterly working capital is now -47.45% below its all-time high of $11.10 billion, reached on 30 September 2023.VRTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.0% | -47.5% |
| 3 y3 years | +69.4% | -16.0% |
| 5 y5 years | +289.2% | +72.1% |
VRTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +69.4% | -47.5% | +8.1% |
| 5 y | 5 years | at high | +289.2% | -47.5% | +72.1% |
| alltime | all time | at high | >+9999.0% | -47.5% | >+9999.0% |
Vertex Pharmaceuticals Incorporated Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.83 B(+8.1%) |
| June 2024 | - | $5.39 B(-43.2%) |
| Mar 2024 | - | $9.49 B(-10.4%) |
| Dec 2023 | $10.60 B(+1.0%) | $10.60 B(-4.5%) |
| Sept 2023 | - | $11.10 B(+5.5%) |
| June 2023 | - | $10.52 B(+5.8%) |
| Mar 2023 | - | $9.94 B(-5.3%) |
| Dec 2022 | $10.49 B(+41.4%) | $10.49 B(+8.6%) |
| Sept 2022 | - | $9.66 B(+8.0%) |
| June 2022 | - | $8.95 B(+9.4%) |
| Mar 2022 | - | $8.18 B(+10.3%) |
| Dec 2021 | $7.42 B(+18.6%) | $7.42 B(+6.9%) |
| Sept 2021 | - | $6.94 B(+4.8%) |
| June 2021 | - | $6.62 B(+0.4%) |
| Mar 2021 | - | $6.60 B(+5.4%) |
| Dec 2020 | $6.26 B(+79.4%) | $6.26 B(+14.7%) |
| Sept 2020 | - | $5.45 B(+11.4%) |
| June 2020 | - | $4.90 B(+25.3%) |
| Mar 2020 | - | $3.91 B(+12.0%) |
| Dec 2019 | $3.49 B(+28.1%) | $3.49 B(+2.9%) |
| Sept 2019 | - | $3.39 B(-1.8%) |
| June 2019 | - | $3.45 B(+12.2%) |
| Mar 2019 | - | $3.08 B(+13.0%) |
| Dec 2018 | $2.72 B(+47.8%) | $2.72 B(+1.1%) |
| Sept 2018 | - | $2.69 B(+8.6%) |
| June 2018 | - | $2.48 B(+12.0%) |
| Mar 2018 | - | $2.21 B(+20.2%) |
| Dec 2017 | $1.84 B(+77.3%) | $1.84 B(+13.9%) |
| Sept 2017 | - | $1.62 B(+4.0%) |
| June 2017 | - | $1.56 B(+12.5%) |
| Mar 2017 | - | $1.38 B(+33.0%) |
| Dec 2016 | $1.04 B(+15.3%) | $1.04 B(+33.4%) |
| Sept 2016 | - | $779.06 M(-6.3%) |
| June 2016 | - | $831.29 M(-2.3%) |
| Mar 2016 | - | $850.79 M(-5.6%) |
| Dec 2015 | $900.99 M(-23.5%) | $900.99 M(-8.5%) |
| Sept 2015 | - | $984.49 M(+6.9%) |
| June 2015 | - | $920.87 M(-12.8%) |
| Mar 2015 | - | $1.06 B(-10.4%) |
| Dec 2014 | $1.18 B(-1.0%) | $1.18 B(-7.8%) |
| Sept 2014 | - | $1.28 B(+29.8%) |
| June 2014 | - | $984.41 M(-6.9%) |
| Mar 2014 | - | $1.06 B(-11.2%) |
| Dec 2013 | $1.19 B(+2.9%) | $1.19 B(-3.9%) |
| Sept 2013 | - | $1.24 B(-7.2%) |
| June 2013 | - | $1.33 B(+15.3%) |
| Mar 2013 | - | $1.16 B(+0.1%) |
| Dec 2012 | $1.16 B(+23.2%) | $1.16 B(-5.8%) |
| Sept 2012 | - | $1.23 B(+1.2%) |
| June 2012 | - | $1.21 B(+12.4%) |
| Mar 2012 | - | $1.08 B(+15.0%) |
| Dec 2011 | $938.91 M(+61.3%) | $938.91 M(+34.7%) |
| Sept 2011 | - | $696.88 M(+100.2%) |
| June 2011 | - | $348.16 M(-23.8%) |
| Mar 2011 | - | $456.78 M(-21.6%) |
| Dec 2010 | $582.26 M(-43.0%) | $582.26 M(-36.4%) |
| Sept 2010 | - | $914.87 M(+28.5%) |
| June 2010 | - | $712.18 M(-22.2%) |
| Mar 2010 | - | $915.23 M(-10.5%) |
| Dec 2009 | $1.02 B(+57.0%) | $1.02 B(+49.7%) |
| Sept 2009 | - | $682.70 M(+14.0%) |
| June 2009 | - | $599.08 M(-17.1%) |
| Mar 2009 | - | $722.87 M(+11.0%) |
| Dec 2008 | $651.02 M(+118.8%) | $651.02 M(-15.7%) |
| Sept 2008 | - | $772.55 M(+14.5%) |
| June 2008 | - | $674.73 M(+10.5%) |
| Mar 2008 | - | $610.62 M(+105.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $297.57 M(-42.8%) | $297.57 M(-16.8%) |
| Sept 2007 | - | $357.57 M(-17.8%) |
| June 2007 | - | $434.75 M(-18.3%) |
| Mar 2007 | - | $531.95 M(+2.2%) |
| Dec 2006 | $520.39 M(+82.7%) | $520.39 M(-10.5%) |
| Sept 2006 | - | $581.25 M(+69.0%) |
| June 2006 | - | $343.85 M(+19.5%) |
| Mar 2006 | - | $287.81 M(+1.1%) |
| Dec 2005 | $284.81 M(+15.4%) | $284.81 M(-5.9%) |
| Sept 2005 | - | $302.52 M(-7.6%) |
| June 2005 | - | $327.32 M(+62.2%) |
| Mar 2005 | - | $201.86 M(-18.2%) |
| Dec 2004 | $246.89 M(-45.7%) | $246.89 M(-17.3%) |
| Sept 2004 | - | $298.39 M(-11.4%) |
| June 2004 | - | $336.76 M(-18.4%) |
| Mar 2004 | - | $412.60 M(-9.3%) |
| Dec 2003 | $454.74 M(-23.2%) | $454.74 M(-7.3%) |
| Sept 2003 | - | $490.45 M(-12.8%) |
| June 2003 | - | $562.72 M(-12.3%) |
| Mar 2003 | - | $641.68 M(+8.4%) |
| Dec 2002 | $591.98 M(-13.5%) | $591.98 M(-3.7%) |
| Sept 2002 | - | $614.87 M(-4.7%) |
| June 2002 | - | $645.32 M(-2.0%) |
| Mar 2002 | - | $658.24 M(-3.8%) |
| Dec 2001 | $684.54 M(+57.9%) | $684.54 M(+103.4%) |
| Sept 2001 | - | $336.52 M(+15.4%) |
| June 2001 | - | $291.62 M(-3.2%) |
| Mar 2001 | - | $301.41 M(-30.5%) |
| Dec 2000 | $433.44 M(+145.3%) | $433.44 M(-17.0%) |
| Sept 2000 | - | $522.35 M(+44.7%) |
| June 2000 | - | $360.93 M(+6.9%) |
| Mar 2000 | - | $337.71 M(+91.1%) |
| Dec 1999 | $176.68 M(-25.0%) | $176.68 M(-2.4%) |
| Sept 1999 | - | $181.00 M(-8.2%) |
| June 1999 | - | $197.10 M(-7.4%) |
| Mar 1999 | - | $212.90 M(-9.6%) |
| Dec 1998 | $235.60 M(-12.1%) | $235.60 M(-5.6%) |
| Sept 1998 | - | $249.70 M(+0.2%) |
| June 1998 | - | $249.20 M(-3.7%) |
| Mar 1998 | - | $258.80 M(-3.4%) |
| Dec 1997 | $267.90 M(+114.1%) | $267.90 M(-2.1%) |
| Sept 1997 | - | $273.70 M(-1.7%) |
| June 1997 | - | $278.50 M(+4.0%) |
| Mar 1997 | - | $267.70 M(+114.0%) |
| Dec 1996 | $125.10 M(+58.2%) | $125.10 M(-1.5%) |
| Sept 1996 | - | $127.00 M(+132.2%) |
| June 1996 | - | $54.70 M(-23.1%) |
| Mar 1996 | - | $71.10 M(-10.1%) |
| Dec 1995 | $79.10 M(-21.6%) | $79.10 M(-1.0%) |
| Sept 1995 | - | $79.90 M(-7.6%) |
| June 1995 | - | $86.50 M(-8.7%) |
| Mar 1995 | - | $94.70 M(-6.1%) |
| Dec 1994 | $100.90 M(+120.3%) | $100.90 M(+12.5%) |
| Sept 1994 | - | $89.70 M(-5.6%) |
| June 1994 | - | $95.00 M(-5.2%) |
| Mar 1994 | - | $100.20 M(+118.8%) |
| Dec 1993 | $45.80 M(+14.2%) | $45.80 M(+24.8%) |
| Sept 1993 | - | $36.70 M(-6.1%) |
| June 1993 | - | $39.10 M(+8.6%) |
| Mar 1993 | - | $36.00 M(-10.2%) |
| Dec 1992 | $40.10 M(-18.2%) | $40.10 M(-8.0%) |
| Sept 1992 | - | $43.60 M(-3.5%) |
| June 1992 | - | $45.20 M(-3.0%) |
| Mar 1992 | - | $46.60 M(-4.9%) |
| Dec 1991 | $49.00 M(+1533.3%) | $49.00 M(+95.2%) |
| Sept 1991 | - | $25.10 M(+8266.7%) |
| June 1991 | - | $300.00 K(-90.0%) |
| Dec 1990 | $3.00 M | $3.00 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual working capital?
- What is the all time high annual working capital for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual working capital year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly working capital?
- What is the all time high quarterly working capital for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly working capital year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual working capital?
The current annual working capital of VRTX is $10.60 B
What is the all time high annual working capital for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual working capital is $10.60 B
What is Vertex Pharmaceuticals Incorporated annual working capital year-on-year change?
Over the past year, VRTX annual working capital has changed by +$104.10 M (+0.99%)
What is Vertex Pharmaceuticals Incorporated quarterly working capital?
The current quarterly working capital of VRTX is $5.83 B
What is the all time high quarterly working capital for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly working capital is $11.10 B
What is Vertex Pharmaceuticals Incorporated quarterly working capital year-on-year change?
Over the past year, VRTX quarterly working capital has changed by -$5.27 B (-47.45%)